Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-18 06:01 am Purchase | 13G | PROTARA THERAPEUTICS INC TARA | Opaleye Management Inc. | 1,681,154 8.150% | 1,681,154 (New Position) | View |
2024-11-14 1:00 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | Woodline Partners LP | 1,576,567 7.400% | 1,576,567 (New Position) | View |
2024-11-14 12:19 pm Unchanged | 13G | PROTARA THERAPEUTICS INC TARA | CVI Investments Inc. | 600,380 2.800% | 0 (Unchanged) | View |
2024-04-25 8:43 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | RA CAPITAL MANAGEMENT L.P. | 2,073,075 9.990% | 2,073,075 (New Position) | View |
2024-04-22 4:05 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | CITADEL ADVISORS LLC | 1,213,132 5.700% | 1,213,132 (New Position) | View |
2024-04-09 10:43 am Purchase | 13G | PROTARA THERAPEUTICS INC TARA | CVI Investments Inc. | 600,380 5.300% | 600,380 (New Position) | View |
2024-02-14 7:11 pm Sale | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 0 0.000% | -671,741 (Position Closed) | View |
2023-02-14 4:52 pm Unchanged | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 671,741 6.000% | 0 (Unchanged) | View |
2022-02-14 6:59 pm Sale | 13G | PROTARA THERAPEUTICS INC TARA | PERCEPTIVE ADVISORS LLC | 421,641 3.800% | -186,903 (-30.71%) | View |
2022-02-14 6:27 pm Sale | 13G | PROTARA THERAPEUTICS INC TARA | Rock Springs Capital Management LP | 0 0.000% | -643,200 (Position Closed) | View |
2022-02-14 4:39 pm Sale | 13G | PROTARA THERAPEUTICS INC TARA | Ikarian Capital LLC | 279,256 2.500% | -370,286 (-57.01%) | View |
2022-02-11 4:40 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 671,741 6.000% | 671,741 (New Position) | View |
2021-02-16 4:32 pm Sale | 13G | PROTARA THERAPEUTICS INC TARA | Rock Springs Capital Management LP | 643,200 5.740% | -422 (-0.07%) | View |
2021-02-16 3:38 pm Unchanged | 13G | PROTARA THERAPEUTICS INC TARA | PERCEPTIVE ADVISORS LLC | 608,544 5.400% | 0 (Unchanged) | View |
2021-02-12 4:31 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | Ikarian Capital LLC | 649,542 5.800% | 649,542 (New Position) | View |
2021-01-08 3:32 pm Unchanged | 13D | PROTARA THERAPEUTICS INC TARA | Flynn James E | 0 0.000% | 0 (Unchanged) | View |
2020-10-02 3:38 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | Rock Springs Capital Management LP | 643,622 6.160% | 643,622 (New Position) | View |
2020-10-01 4:09 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | PERCEPTIVE ADVISORS LLC | 608,544 5.800% | 608,544 (New Position) | View |
2020-09-25 5:20 pm Sale | 13D | PROTARA THERAPEUTICS INC TARA | Opaleye Management Inc. | 2,508,472 23.860% | -2,527,538 (-50.19%) | View |
2020-02-21 12:27 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | Ikarian Capital LLC | 307,308 5.300% | 307,308 (New Position) | View |